A large number of viruses are capable of inducing acute or chronic hep
atitis, The syndrome of chronic hepatitis encompasses not only viral b
ut also autoimmune liver diseases. The hepatitis C virus, and recently
also the hepatitis D virus have been found to be associated with an a
rray of autoimmune syndromes, diseases and markers of autoimmunity, Th
e relationship of hepatotropic virus infection and the immune system l
eading to virus-associated autoimmunity, and its distinction from genu
ine autoimmune disease represents a fascinating field of research, Cli
nically, the differentiation between autoimmune liver diseases, virus
infection and virus-associated autoimmunity is difficult and epidemiol
ogical evaluations have not come up with universally applicable and va
lid classification criteria, However, both autoimmune liver diseases a
nd viral hepatitis can readily be diagnosed and distinguished through
precise and molecularly determined immunological testing systems, The
overlap of both, virus-associated autoimmunity, is still at the centre
of research activities aimed at establishing diagnostic and risk-asse
ssment criteria. Studies of molecular autoantigens and autoepitopes ha
ve begun to define the differences of the B-cell response in autoimmun
e disease and virus-associated autoimmunity. This provides data that m
ay contribute to the safe application of therapeutic strategies as dif
ferent as immunosuppression and interferon-alpha (IFN-alpha). The pres
ent review focuses on the clinical, epidemilogical and molecular aspec
ts of these disease entities.